← All organizations

Effector Therapeutics

For profitWebsite ↗

Also known as: Effector Therapeutics | eFFECTOR Therapeutics, Inc. | eFFECTOR Therapuetics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 29, 2023

Timeline

2010s

Jun 1, 2012
Effector Therapeutics— Founded

Drugs by trial phase (5 distinct, 11 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

paclitaxel

Indications

Studied for

Recent trials (16)

NCT05744739CollaboratorPhase 1Sep 29, 2023
NCT04622007Lead sponsorPhase 2Dec 18, 2020
NCT04622007Study directorPhase 2Dec 18, 2020
NCT04632381Study directorPhase 1Nov 16, 2020
NCT04632381Lead sponsorPhase 1Nov 16, 2020
NCT04261218CollaboratorPhase 1Feb 29, 2020
NCT04092673Lead sponsorPhase 1/Phase 2Sep 30, 2019
NCT03690141Study chairPhase 2Sep 30, 2018
NCT03690141Lead sponsorPhase 2Sep 30, 2018
NCT03616834Lead sponsorPhase 2Jul 25, 2018
NCT03616834Study chairPhase 2Jul 25, 2018
NCT03318562Lead sponsorPhase 2Nov 17, 2017
NCT03258398Lead sponsorPhase 2Sep 13, 2017
NCT02937675Lead sponsorPhase 1/Phase 2Oct 1, 2016
NCT02605083Study directorPhase 1/Phase 2Nov 1, 2015

Details

Founded: San Diego, CA, US Jun 1, 2012
Last known activity: Sep 29, 2023